MS Views and News

MS Views and News
Click Logo - MS Views & News is Dedicated to Providing You with Multiple Sclerosis News and Information

Thursday, June 17, 2010

MSVN News: ORAL MS MEDS, Mental Activity, CCVSI


Stu's Views and MS Related News
A product of:
"Providing You with 'MS Views and News', is What We Do"
Today is June 17, 2010

***********************************************************
OUR MISSION:
'MS Views and News' (MSVN) is dedicated to the global collection and distribution of current information concerning Multiple Sclerosis. In collaboration with other organizations, 'MS Views and News' uses state-of-the-art communication channels to provide information for those affected by, or interested in MS.
"MS Views and News" is a 501©(3) Not for Profit organization
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

LAST week we had a HUGE issue. If you missed it and want to take a peek, see where I archive my e-newsletters by clicking here.

See all the new share links found on my MS Blog. CLICK, then scroll down on right side. Continue scrolling to see all the helpful information.

VISIT with our Sponsor links by clicking on their banners found on our website: http://www.msviewsandnews.org

YOUR help is needed to help educate. Consider yourself a teacher and an enabler of providing MS information.

HELP ME and MS Views and News (MSVN) provide education. CLICK to Donate via PayPal.
Large or small, every dollar counts and every dollar is needed to allow us to grow and continue to provide for others. OR contact me to directly to make a secure credit card donation over the phone or via email. Your contribution is Tax Deductible and is kept anonymous.

Please review each week, our fundraiser auction site, where you may find items of interest.

======================================================
In this week's edition we have:
A week's worth of news all found in this edition of Stu's Views and MS Related News

======================================================

THIS week's ( 13 ) Postings: (click each to review)
Take your time reviewing the information found here. After all, you have a week before my next edition.

Remember that if you ever miss an e-newsletter, you can always find it in our
e-newsletter archives. Information found near to the top of this page.
    ======================================================

    e-Newsletter Disclaimer:

    ***Editor's Note: The intent of this newsletter is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~


    Friday, June 11, 2010

    Test Posting of e-newsletter

    Stu's Views and MS News
    e-Newsletter
    'MS Views and News' is unique in what we do. Bridging the gap to all major MS Organizations.
    Providing information and resources from our website, daily via our blog and weekly by our
    e-newsletter .
    --------------------------------------------------------------
    In this week's edition:
    Stem Cell, CCSVI, Oral therapies, Handling the heat, Readying for your Appt with Neurologist.
    --------------------------------------------------------------
    Tell us what you think of the design of
    this new e-newsletter, Write to:
    --------------------------------------------------------------

    "Providing You with
    'MS Views and News',
    is What We Do"
    _______________________________


    CLICK BELOW TO DONATE




    MSV&N is a 501©(3) organization as recognized by the Internal Revenue Service. Your gift is tax deductible to the extent permitted by law.

    This Week's Postings...
    Click each to review


    Recent News


    Study of “Liberation Treatment” to Launch in Buffalo
    The University of Buffalo has announced that researchers there, led by the department of neurosurgery, have embarked on a landmark prospective randomized double-blinded study to test the safety and efficacy of interventional endovascular therapy—dubbed “liberation treatment”—on MS symptoms and progression. Ever since Paolo Zamboni, M.D., of the University of Ferrara, Italy, proposed more than a year ago that a blockage of major venous outflow from the brain and spinal cord in people with MS (a condition known as CCSVI) may be associated with the disease, the MS community has been anxious for further studies to distinguish the role of CCSVI in MS.

    PREMiSe (Prospective Randomized Endovascular therapy in Multiple Sclerosis) is a study to determine if endovascular intervention via balloon angioplasty to correct the blockages improves MS symptoms or progression
    To continue reading, click here

    Headline News
    Other MSVN sites ~...~...


    * View our e-newsletter archives by clicking here.
    * VISIT with our Sponsor links by clicking on their banners found on our website: http://www.msviewsandnews.org
    * Please visit the MS Views and News Bidding for Good Auction site. Click here to see what is available.

    OUR MISSION: 'MS Views and News' (MSVN) is dedicated to the global collection and distribution of current information concerning Multiple Sclerosis. In collaboration with other organizations, 'MS Views and News' uses state-of-the-art communication channels to provide information for those affected by, or interested in MS.
    _______________________________________________________________________
    e-Newsletter Disclaimer:
    ***Editor's Note: The intent of this newsletter is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.